COMPANY SUMMARY
Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; implanted medical devices, implanted leads, procedure accessories, and external devices; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; orthopedics, minimally invasive surgery, and general surgery devices; and portable medical devices, including patient monitoring, ventilators, portable defibrillators, portable ultrasound, and X-Ray machines. Furthermore, the company provides medical technologies; supplies medical stamped components, and shallow and deep draw casings and assemblies; and epicardial pacing leads. It serves multi-national original equipment manufacturers and affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, cardio and vascular, and advanced surgical and portable medical markets. The company provides its products under the Greatbatch Medical and the Lake Region Medical brands. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.
Financial Summary
| Share Statistics |
ITGR |
Industry Median |
Percentile (All Stocks) |
| Market Cap (Mil) |
$4,115.7 |
$337.2 |
64% |
|
| Shares Out (Mil) |
34.4 |
41.9 |
40% |
|
| Institutional Ownership |
98.8% |
77.8% |
82% |
|
| Float (Mil) |
33.5 |
34.7 |
39% |
|
| Beta |
0.65 |
0.85 |
38% |
|
| Avg Daily Volume (000s) |
610 |
278 |
62% |
|
Price Change (52-week) |
11.5% |
58.7% |
55% |
|
| Growth |
ITGR |
Industry Median |
Percentile (All Stocks) |
| Sales (5yr) |
11.5% |
11.8% |
64% |
|
| Net Income (5yr) |
5.9% |
(5.8%) |
48% |
|
| EPS (5yr) |
4.4% |
11.4% |
37 |
|
| Dividends (5yr) |
0.0% |
0.0% |
0% |
|
| Cash Flow (5yr) |
(22.7%) |
(16.3%) |
28% |
|
| Estimates |
Qtrly |
Current Fiscal Year |
Next Fiscal Year |
| # of Estimates |
9 |
10 |
9 |
| Current EPS |
$1.382 |
$6.084 |
$6.819 |
| Month Ago EPS |
$1.381 |
$6.082 |
$6.808 |
| # Rev Up |
2 |
1 |
1 |
| # Rev Down |
0 |
0 |
0 |
| Three Months Ago EPS |
$1.381 |
$6.122 |
$6.852 |
| Year/Year Chg |
187.9% |
110.5% |
151.7% |
| Financials |
ITGR |
Industry Median |
Percentile (All Stocks) |
| Sales (TTM) (Mil) |
$1,856 |
$152 |
59% |
|
| Net Income (TTM) (Mil) |
$142 |
($10) |
64% |
|
| EPS (TTM) |
$4.072 |
($0.500) |
84% |
|
| Operating Cash Flow (TTM) (Mil) |
$190 |
($2) |
59% |
|
| Net Cash Flow (TTM) (Mil) |
($24) |
$1 |
25% |
|
| Long-Term Debt (Q1) (Mil) |
$1,373 |
$22 |
70% |
|
| Enterprise Value (Q1) (Mil) |
$4,462 |
$304 |
61% |
|
| Valuation |
ITGR |
Industry Median |
Percentile (All Stocks) |
| P/B |
2.42 |
2.80 |
58% |
|
| P/E |
30.5 |
31.1 |
69% |
|
| Dividend Yield |
0.0% |
0.0% |
0% |
|
| PEG (5yr hist) |
6.9 |
1.9 |
91% |
|
| Ratios |
ITGR |
Industry Median |
Percentile (All Stocks) |
| Gross Margin |
26.8% |
59.1% |
30% |
|
| Net Margin |
7.6% |
(7.3%) |
57% |
|
| ROA |
4.2% |
(13.7%) |
68% |
|
| ROE |
8.6% |
(15.8%) |
53% |
|
| Liabilities to Assets |
50.3% |
44.7% |
42% |
|
| F-Score |
5 |
4 |
na |
|
Passing Stock Screens
As of 7/31/2026, from a list of 60 stock screening strategies,
ITGR meetings the criteria of 2 screen:
Stock Screen
GURU STRATEGY
Lakonishok Screen
Factors: Value, Momentum
Identifying stocks trading at a discount to their industry norms but showing recent price strength and upward earnings revisions.
FACTOR STRATEGY
P/E Relative Screen
Factors: Value, Earnings Estimates
A screen that looks at the relationship of a stock's price-earnings ratio to that of the industry and market.